| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Abiraterone | Abiraterone Acetate Diastereomer | VL830014 | View |
| Abiraterone | Abiraterone Acetate N-Oxide | VL830049 | View |
| Abiraterone | Abiraterone Acetate Reduced Impurity | VE0010716 | View CAS 2141996-19-0 |
| Abiraterone | Abiraterone Acetate-5, 6-Epoxide | VL830024 | View |
| Abiraterone | Abiraterone Dimer Impurity | VL830012 | View CAS 2484719-09-5 |
| Abiraterone | Abiraterone Epoxide Impurity | VL830017 | View |
| Abiraterone | Abiraterone Ethyl Ether Impurity | VL830020 | View |
| Abiraterone | Abiraterone Isopropyl Ether | VL830021 | View CAS 2484719-15-3 |
| Abiraterone | Abiraterone Mesylate | VL830040 | View |
| Abiraterone | Abiraterone N-Oxide Impurity | VL830002 | View |
| Abiraterone | Abiraterone Related Compound 2 (Prasterone Triflate) | VL830009 | View CAS 124643-35-2 |
| Abiraterone | Abiraterone Related Compound 4 | VL830010 | View CAS 115375-60-5 |
| Abiraterone | Abiraterone Related Compound 5 | VL830011 | View |
| Abiraterone | Abiraterone Related Compound 6 | VL830023 | View |
| Abiraterone | Abiraterone Related Compound 7 | VL830025 | View CAS 186826-68-6 |
| Abiraterone | Abiraterone Related Compound 8 | VL830027 | View |
| Abiraterone | Abiraterone Related Compound 9 | VL830026 | View CAS 154229-26-2 |
| Abiraterone | Abiraterone Sulfate Sodium Salt | VL830037 | View CAS 1993430-25-3 |
| Abiraterone | Abiraterone Tosylate Impurity | VL830050 | View |
| Abiraterone | Abiraterone-5, 6-Epoxide | VL830013 | View |
| Abiraterone | Abiraterone-beta-D-Glucuronide | VL830048 | View |
| Abiraterone | Abiratetone Succinate | VL830029 | View |
| Abiraterone | Alpha-Epoxyabiraterone Acetate | VE006953 | View CAS 2484719-11-9 |
| Abiraterone | Anhydro Abiraterone | VL830016 | View CAS 154229-20-6 |
| Abiraterone | Beta-Epoxyabiraterone Acetate | VE006954 | View CAS 2484719-26-6 |
| Abiraterone | Dehydroepiandrosterone Sulfate Sodium Salt | VL830044 | View CAS 651-48-9 |
| Abiraterone | O-Chlorobutylabiraterone | VL830019 | View CAS 2484719-17-5 |
| Abiraterone | 16-Dehydro Pregnenolone Acetate (DHPG Acetate) | VL830004 | View CAS 979-02-2 |
| Abiraterone | 16-Dehydro Pregnenolone Acetate Oxime (DHPG Oxime Acetate) | VL830003 | View CAS 2174-13-2 |
| Abiraterone | 2, 4, 6-Trichloro-N-(imidazolidin-2-ylidene)aniline | VE008565 | View |
| Abiraterone | 3-Deoxy 3-Chloro Abiraterone | VL830022 | View |
| Abiraterone | 3-Deoxy-3-acetyl abiraterone-3-ene | VE006955 | View |
| Abiraterone | 7 Keto Abiraterone Acetate | VL830001 | View |
Abiraterone Related Compound
Abiraterone is used to treat advanced prostate cancer. It is typically prescribed to men whose cancer has not responded to other forms of hormone treatment.
References
- Schmidt, Charlie. “Treatment with Abiraterone Significantly Improves Survival in Advanced Prostate Cancer – Harvard Health.” Harvard Health, Harvard Health, 28 Jan. 2022, www.health.harvard.edu/blog/treatment-with-abiraterone-significantly-improves-survival-in advanced-prostate-cancer-202201282678.
- “Enzalutamide Has Benefits When Taken after Abiraterone by Men with Metastatic Prostate Cancer.” PCFA, 2019, www.pcfa.org.au/news-media/news/enzalutamide-has benefits-when taken-after-abiraterone-by-men-with-metastatic-prostate-cancer/.
- Rescigno, Pasquale, et al. “Prostate-Specific Antigen Decline after 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration Resistant Prostate Cancer.” European Urology, vol. 70, no. 5, Nov. 2016, pp. 724–31, https://doi.org/10.1016/j.eururo.2016.02.055.
FAQ’s
Can abiraterone be used to treat prostate cancer?
Abiraterone treatment greatly increases survival in advanced prostate cancer. In December,
researchers published the results of a trial indicating that the medicine abiraterone reduces the chance of prostate cancer death in a subset of patients who would not have received it otherwise.
Which medicine is commonly used in combination with abiraterone to treat prostate cancer?
Men with metastatic prostate cancer who take Enzalutamide after Abiraterone benefit from it.
How long does abiraterone take to reduce PSA?
Prostate-specific antigen decline and overall survival in patients with metastatic castration resistant prostate cancer after 4 weeks of treatment with abiraterone acetate.
